Last updated: 2026-09-16 12:10:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
CeriBell, Inc. (CBLL) operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $25.03, with a market capitalisation of $933.74M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $10.85 to $25.33. This page covers its latest market performance, valuation, price trends and company information.
$933.74M | |
$25.03 | |
$32.75 | |
$10.01 | |
$25.04 | |
49.00 | |
387.51K | |
-- | |
$25.33 | |
$10.85 | |
-- | |
-- |
CeriBell, Inc. (CBLL) is trading at $25.03 in pre-market trading as of 2026-09-16 11:50:00, down 0.06% ($0.02) from the previous close of $25.04
Pre-market trading shows how investors are pricing CBLL before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Over the past seven days, CeriBell, Inc. (CBLL) moved from $24.72 to $25.03, representing a gain of 1.23% ($0.30).
The stock traded between $23.04 and $25.12 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 265.09 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 97.9%
CBLL is currently trading at $25.03, placing it 97.9% of the way from its 52-week low of $10.85 to its 52-week high of $25.33. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 300 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of CeriBell, Inc. (CBLL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.